Diabetes
Conference Coverage
Could a type 2 diabetes drug tackle kidney stones?
“If this association is proven, empagliflozin may be used to decrease the risk of kidney stones at least in those with type 2 diabetes, but maybe...
Latest News
What’s the best time of day to exercise? It depends on your goals
When you exercise can ultimately have a big effect in terms of strength, fat loss, heart health, mood, and quality of sleep.
From the Journals
Heart failure: Medicare cost sharing may put quadruple therapy out of reach
Patients’ out-of-pocket costs are highest for the most effective medications.
Conference Coverage
Ultra-processed: Doctors debate whether putting this label on foods is useful
Some experts say increased awareness and labeling of ultra-processed foods can only be a good thing. Others say that the classification system...
Conference Coverage
Experts elevate new drugs for diabetic kidney disease
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow...
Conference Coverage
Diabetes tied to risk of long COVID, too
Roughly 43% of studies in a literature review identified diabetes as a risk factor for postacute sequelae of COVID-19.
Conference Coverage
Exercise of any type boosts type 1 diabetes time in range
Aerobic, interval, and resistance training all were significantly associated with improved glucose time in range, compared to no exercise.
Conference Coverage
‘DIY’ artificial pancreas systems found to be safe, effective: CREATE trial
So-called “do it yourself” artificial pancreas systems predate commercially available automated insulin delivery systems, but many people with...
Conference Coverage
Prediabetes is linked independently to myocardial infarction
A history of prediabetes is predictor of MI independent of any other risk factor, suggesting that screening efforts should increase.
Conference Coverage
Avexitide promising for hypoglycemia after weight-loss surgery
The GLP-1 receptor antagonist reduced all levels of hypoglycemia, by different measures, and in patients who had undergone different bariatric...
Conference Coverage
SGLT2 inhibitors cut AFib risk in real-word analysis
Observational data add to a growing link between SGLT2 inhibitor treatment and atrial fibrillation prevention in people with type 2 diabetes.